Stefanie C. Fas

1.5k total citations
15 papers, 1.3k citations indexed

About

Stefanie C. Fas is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Stefanie C. Fas has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Immunology and 3 papers in Epidemiology. Recurrent topics in Stefanie C. Fas's work include Cell death mechanisms and regulation (9 papers), Antibiotic Resistance in Bacteria (3 papers) and Immune Cell Function and Interaction (3 papers). Stefanie C. Fas is often cited by papers focused on Cell death mechanisms and regulation (9 papers), Antibiotic Resistance in Bacteria (3 papers) and Immune Cell Function and Interaction (3 papers). Stefanie C. Fas collaborates with scholars based in Germany, United States and France. Stefanie C. Fas's co-authors include Peter H. Krammer, Andreas Krueger, Sven Baumann, Marco Giaisi, Min Li‐Weber, Muh‐Ching Yee, Thomas J. Wandless, Karlene A. Cimprich, Anette Merling and Michael P. Rudolf and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Blood.

In The Last Decade

Stefanie C. Fas

15 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefanie C. Fas Germany 14 665 386 181 169 144 15 1.3k
Suparerk Borwornpinyo Thailand 20 587 0.9× 212 0.5× 90 0.5× 115 0.7× 76 0.5× 87 1.3k
Sanjay Kumar India 22 704 1.1× 661 1.7× 184 1.0× 107 0.6× 117 0.8× 70 1.8k
Nathan A. Lack Türkiye 22 668 1.0× 218 0.6× 169 0.9× 128 0.8× 52 0.4× 55 1.4k
K. Tsukamoto Japan 19 738 1.1× 445 1.2× 208 1.1× 160 0.9× 113 0.8× 50 1.7k
Shridhar Bhat United States 21 1.5k 2.3× 203 0.5× 331 1.8× 345 2.0× 133 0.9× 37 2.6k
Nathan P. Coussens United States 18 969 1.5× 522 1.4× 234 1.3× 114 0.7× 59 0.4× 47 1.8k
Hanjie Yu China 20 923 1.4× 360 0.9× 122 0.7× 156 0.9× 34 0.2× 82 1.4k
Hong Namkoong South Korea 20 780 1.2× 327 0.8× 371 2.0× 201 1.2× 50 0.3× 35 1.6k
Shenping Liu United States 21 1.2k 1.8× 184 0.5× 439 2.4× 240 1.4× 141 1.0× 39 2.1k
Kirsten Harmrolfs Germany 19 626 0.9× 474 1.2× 108 0.6× 82 0.5× 400 2.8× 32 1.4k

Countries citing papers authored by Stefanie C. Fas

Since Specialization
Citations

This map shows the geographic impact of Stefanie C. Fas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie C. Fas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie C. Fas more than expected).

Fields of papers citing papers by Stefanie C. Fas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie C. Fas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie C. Fas. The network helps show where Stefanie C. Fas may publish in the future.

Co-authorship network of co-authors of Stefanie C. Fas

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie C. Fas. A scholar is included among the top collaborators of Stefanie C. Fas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie C. Fas. Stefanie C. Fas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Sécher, Thomas, Louis Fauconnier, Agata Szade, et al.. (2011). Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection. Journal of Antimicrobial Chemotherapy. 66(5). 1100–1109. 42 indexed citations
3.
Horn, Michael P., Adrian W. Zuercher, Martin A. Imboden, et al.. (2010). PreclinicalIn VitroandIn VivoCharacterization of the Fully Human Monoclonal IgM Antibody KBPA101 Specific forPseudomonas aeruginosaSerotype IATS-O11. Antimicrobial Agents and Chemotherapy. 54(6). 2338–2344. 47 indexed citations
4.
Baumann, Sven, Stefanie C. Fas, Marco Giaisi, et al.. (2007). Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCγ1- and Ca2+-dependent apoptosis. Blood. 111(4). 2354–2363. 136 indexed citations
5.
Fas, Stefanie C., Sven Baumann, Andreas Krueger, et al.. (2006). In vitro generated human memory‐like T cells are CD95 type II cells and resistant towards CD95‐mediated apoptosis. European Journal of Immunology. 36(11). 2894–2903. 13 indexed citations
6.
Fas, Stefanie C., Sven Baumann, Jia Zhu, et al.. (2006). Wogonin sensitizes resistant malignant cells to TNFα- and TRAIL-induced apoptosis. Blood. 108(12). 3700–3706. 93 indexed citations
7.
Krueger, Andreas, Stefanie C. Fas, Marco Giaisi, et al.. (2006). HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP). Blood. 107(10). 3933–3939. 70 indexed citations
8.
Yee, Muh‐Ching, et al.. (2005). A Cell-permeable, Activity-based Probe for Protein and Lipid Kinases. Journal of Biological Chemistry. 280(32). 29053–29059. 148 indexed citations
9.
Fas, Stefanie C., Benedikt Fritzsching, Elisabeth Suri‐Payer, & Peter H. Krammer. (2005). Death Receptor Signaling and Its Function in the Immune System. PubMed. 9. 1–17. 53 indexed citations
10.
Baumann, Sven, Natalia Novac, Anton Bauer, et al.. (2005). Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer. Blood. 106(2). 617–625. 64 indexed citations
11.
Schulze‐Bergkamen, Henning, Dirk Brenner, Andreas Krueger, et al.. (2004). Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Hepatology. 39(3). 645–654. 99 indexed citations
12.
Schmitz, Ingo, Heiko Weyd, Andreas Krueger, et al.. (2004). Resistance of Short Term Activated T Cells to CD95-Mediated Apoptosis Correlates with De Novo Protein Synthesis of c-FLIPshort. The Journal of Immunology. 172(4). 2194–2200. 72 indexed citations
13.
Ganten, Tom M., Tobias L. Haas, J Sýkora, et al.. (2004). Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Cell Death and Differentiation. 11(S1). S86–S96. 176 indexed citations
14.
Eichhorst, Sören T., Andreas Krueger, Susanne Sebens Müerköster, et al.. (2004). Suramin inhibits death receptor–induced apoptosis in vitro and fulminant apoptotic liver damage in mice. Nature Medicine. 10(6). 602–609. 65 indexed citations
15.
Krueger, Andreas, Stefanie C. Fas, Sven Baumann, & Peter H. Krammer. (2003). The role of CD95 in the regulation of peripheral T‐cell apoptosis. Immunological Reviews. 193(1). 58–69. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026